株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

幹細胞療法の世界市場:分析と予測 - 整形外科・歯科、創傷・外傷、心臓病・神経疾患、免疫疾患・炎症、腫瘍・代謝疾患 (2019-2029年)

Global Stem Cell Therapy Market: Focus on Treatment Type, Cell Source, Indication,11 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029

発行 BIS Research Inc. 商品コード 910165
出版日 ページ情報 英文 230 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
幹細胞療法の世界市場:分析と予測 - 整形外科・歯科、創傷・外傷、心臓病・神経疾患、免疫疾患・炎症、腫瘍・代謝疾患 (2019-2029年) Global Stem Cell Therapy Market: Focus on Treatment Type, Cell Source, Indication,11 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029
出版日: 2019年08月27日 ページ情報: 英文 230 Pages
概要

世界の幹細胞療法市場は、2019年から2029年にかけて27.99%のCAGR (年間複合成長率) で拡大すると予測されています。

当レポートでは、世界の幹細胞療法市場を調査し、市場概要、市場成長への各種影響因子の分析、各セグメント・地域別による分析と予測、および主要企業のプロファイルなどをまとめています。

エグゼクティブサマリー

第1章 製品定義

第2章 調査範囲

第3章 調査手法

第4章 世界の幹細胞療法市場

  • 市場概要
  • 幹細胞療法のイントロダクション
  • 各治療領域における幹細胞の応用
  • 市場ダイナミクス
  • 世界市場のシナリオ
  • 予測の前提条件・制限事項

第5章 競合情勢

  • 概要
  • 主な展開・戦略
  • 市場シェア分析

第6章 産業分析

  • 規制シナリオ
  • 規制指定
  • 優先指定 vs. 従来の認可タイムライン
  • 規制の課題

第7章 世界の幹細胞療法市場:治療タイプ別

  • 概要
  • 主な動向
  • 自家移植治療
  • 同種異系治療

第8章 世界の幹細胞療法市場:細胞源/セルソース別

  • 概要
  • 主な動向
  • 骨髄・末梢血
  • 脂肪組織
  • 胎盤・臍帯
  • その他

第9章 世界の幹細胞療法市場:適応症別

  • 概要
  • 主な動向
  • 整形外科・歯科
  • 創傷・外傷
  • 心臓病・神経疾患
  • 免疫疾患・炎症
  • 腫瘍・代謝疾患
  • その他

第10章 世界の幹細胞療法市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • その他 (ROW)

第11章 企業プロファイル

  • 概要
  • AlloSource
  • ANTEROGEN.CO., LTD.
  • Athersys Inc.
  • CORESTEM, Inc
  • FUJIFILM Cellular Dynamics, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Mesoblast Ltd
  • NuVasive, Inc.
  • Orthofix Holdings, Inc.
  • Osiris Therapeutics, Inc.
  • Regenexx
  • Reliance Life Sciences Private Limited
  • 武田薬品工業
  • U.S. Stem Cell, Inc.
  • Vericel Corporation
図表

List of Tables

  • Table 1: Global Stem Cell Therapy Market, 2018 and 2029
  • Table 6.1: Regulatory Authorities/Associations/Consortiums of the Global Stem Cell Therapy Market
  • Table 7.1: Examples of Companies Offering Autologous Stem Cell Therapy Products
  • Table 7.2: Examples of Companies Offering Allogenic Stem Cell Therapy Products
  • Table 8.1: Examples of Companies Offering Stem Cell Therapy Products Derived from Bone Marrow and Peripheral Blood
  • Table 8.2: Examples of Companies Offering / Developing Stem Cell Therapy Products Derived from Adipose Tissue
  • Table 8.3: Examples of Companies Offering / Developing Stem Cell Therapy Products Derived from Either Placenta or Umbilical Cord
  • Table 8.4: Examples of Companies Developing Stem Cell Therapy Products Derived from Embryonic Stem Cells
  • Table 8.5: Examples of Companies Developing Stem Cell Therapy Products from Different Cell Sources
  • Table 9.1: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Orthopaedic and Dental
  • Table 9.2: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Wounds and Injuries
  • Table 9.3: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Cardiology and Neurology
  • Table 9.4: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Immunology and Inflammatory
  • Table 9.5: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Oncology and Metabolism
  • Table 9.6: Application of Stem Cells in Disease Therapeutics

List of Figures

  • Figure 1: Global Stem Cell Therapy Market Segmentation, 2018 and 2029
  • Figure 2: Share of Key Developments and Strategies, January 2016-July 2019
  • Figure 3: Global Stem Cell Therapy Market Share (by Company), 2018
  • Figure 4: Global Stem Cell Therapy Market Share (by Treatment Type), 2018 and 2029
  • Figure 5: Global Stem Cell Therapy Market Share (by Cell Source), 2018 and 2029
  • Figure 6: Global Stem Cell Therapy Market Share (by Indication), 2018 and 2029
  • Figure 7: Global Stem Cell Therapy Market Share (by Region), 2017 and 2023
  • Figure 2.1: Global Stem Cell Therapy Market Segmentation
  • Figure 3.1: Global Stem Cell Therapy Market Research Methodology
  • Figure 3.2: Primary Research
  • Figure 3.3: Secondary Research
  • Figure 3.4: Data Triangulation
  • Figure 3.5: Bottom-up Approach (Segment-wise Analysis)
  • Figure 3.6: Top-Down Approach (Segment-wise Analysis)
  • Figure 3.7: Assumptions and Limitations
  • Figure 4.1: Drivers and Challenges of the Global Stem Cell Therapy Market
  • Figure 4.2: Global Stem Cell Therapy Market, 2018-2029
  • Figure 5.1: Competitive Landscape (January 2016-June 2019)
  • Figure 5.2: Share of Key Developments and Strategies, January 2016-July 2019
  • Figure 5.3: Collaborations, and Partnerships (by Company), January 2016 and June 2019
  • Figure 5.4: Approvals and Clinical Studies (by Company), January 2016 and June 2019
  • Figure 5.5: Fundings (by Company), January 2016 and June 2019
  • Figure 5.6: Business Expansions (by Company), January 2016 and June 2019
  • Figure 5.7: Product Launches and Developments (by Company), January 2016 and June 2019
  • Figure 5.8: Mergers and Acquisitions (by Company), January 2016 and June 2019
  • Figure 5.9: Market Share Analysis of Global Stem Cell Therapy Market, 2018
  • Figure 7.1: Stem Cells Therapy Market Segmentation (by Treatment Type)
  • Figure 7.2: Global Stem Cell Therapy Market (by Treatment Type), 2018-2029
  • Figure 7.3: Global Autologous Stem Cell Therapy Market, 2018-2029
  • Figure 7.4: Global Stem Cell Therapy Market, by Allogenic Treatment, 2018-2029
  • Figure 8.1: Stem Cells Therapy Market Segmentation (by Cell Source)
  • Figure 8.2: Global Stem Cell Therapy Market (by Cell Source), 2018-2029
  • Figure 8.3: Global Stem Cell Therapy Market (Bone Marrow and Peripheral Blood), 2018-2029
  • Figure 8.4: Global Stem Cell Therapy Market (Adipose Tissue), 2018-2029
  • Figure 8.5: Global Stem Cell Therapy Market (Umbilical Cord and Placenta), 2018-2029
  • Figure 8.6: Global Stem Cell Therapy Market (Embryo), 2018-2029
  • Figure 8.7: Global Stem Cell Therapy Market (Others), 2018-2029
  • Figure 9.1: Stem Cells Therapy Market Segmentation (by Indication)
  • Figure 9.2: Global Stem Cell Therapy Market (by Indication), 2018-2029
  • Figure 9.3: Global Stem Cell Therapy Market (Orthopaedic and Dental), 2018-2029
  • Figure 9.4: Global Stem Cell Therapy Market (Wounds and Injuries), 2018-2029
  • Figure 9.5: Global Stem Cell Therapy Market (Cardiology and Neurology), 2018-2029
  • Figure 9.6: Global Stem Cell Therapy Market (Immunology and Inflammatory), 2018-2029
  • Figure 9.7: Global Stem Cell Therapy Market (Oncology and Metabolism), 2018-2029
  • Figure 9.8: Global Stem Cell Therapy Market (Others), 2018-2029
  • Figure 10.1: Global Stem Cell Therapy Market (by Region), 2018-2029
  • Figure 10.2: North America: Stem Cell Therapy Market, 2018-2029
  • Figure 10.3: North America: Market Dynamics
  • Figure 10.4: North America: Stem Cell Therapy Market (by Country), 2018-2029
  • Figure 10.5: U.S.: Stem Cell Therapy Market, 2018-2029
  • Figure 10.6: Canada: Stem Cell Therapy Market, 2018-2029
  • Figure 10.7: Europe: Stem Cell Therapy Market, 2018-2029
  • Figure 10.8: Europe: Market Dynamics
  • Figure 10.9: Europe: Stem Cell Therapy Market (by Country), 2018-2029
  • Figure 10.10: Germany: Stem Cell Therapy Market, 2018-2029
  • Figure 10.11: U.K.: Stem Cell Therapy Market, 2018-2029
  • Figure 10.12: France: Stem Cell Therapy Market, 2018-2029
  • Figure 10.13: Italy: Stem Cell Therapy Market, 2018-2029
  • Figure 10.14: Rest-of-Europe: Stem Cell Therapy Market, 2018-2029
  • Figure 10.15: Asia-Pacific: Stem Cell Therapy Market, 2018-2029
  • Figure 10.16: Asia-Pacific: Market Dynamics
  • Figure 10.17: Asia-Pacific: Stem Cell Therapy Market (by Country), 2018-2029
  • Figure 10.18: Japan: Stem Cell Therapy Market, 2018-2029
  • Figure 10.19: Australia: Stem Cell Therapy Market, 2018-2029
  • Figure 10.20: China: Stem Cell Therapy Market, 2018-2029
  • Figure 10.21: South Korea: Stem Cell Therapy Market, 2018-2029
  • Figure 10.22: India: Stem Cell Therapy Market, 2018-2029
  • Figure 10.23: Rest-of-Asia-Pacific: Stem Cell Therapy Market, 2018-2029
  • Figure 10.24: Rest-of-the-World: Stem Cell Therapy Market, 2018-2029
  • Figure 10.25: Rest-of-the-World: Market Dynamics
  • Figure 10.26: Rest-of-the-World: Stem Cell Therapy Market (by Region), 2018-2029
  • Figure 10.27: Middle East and Africa: Stem Cell Therapy Market, 2018-2029
  • Figure 10.28: Latin America: Stem Cell Therapy Market, 2018-2029
  • Figure 11.1: Shares of Key Company Profiles
  • Figure 11.2: AlloSource: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.3: AlloSource: SWOT Analysis
  • Figure 11.4: ANTEROGEN.CO., LTD.: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.5: ANTEROGEN.CO., LTD.: SWOT Analysis
  • Figure 11.6: Athersys Inc.: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.7: Athersys Inc.: SWOT Analysis
  • Figure 11.8: CORESTEM, Inc: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.9: CORESTEM, Inc: Overall Financials, 2016-2018
  • Figure 11.10: CORESTEM, Inc: R&D Expenditure (2016-2018)
  • Figure 11.11: CORESTEM, Inc: SWOT Analysis
  • Figure 11.12: FUJIFILM Cellular Dynamics, Inc.: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.13: FUJIFILM Cellular Dynamics, Inc.: Overall Financials, 2016-2018
  • Figure 11.14: FUJIFILM Cellular Dynamics, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 11.15: FUJIFILM Cellular Dynamics, Inc.: Revenue (by Region), 2016-2018
  • Figure 11.16: FUJIFILM Cellular Dynamics, Inc.: R&D Expenditure (2016-2018)
  • Figure 11.17: FUJIFILM Cellular Dynamics, Inc.: SWOT Analysis
  • Figure 11.18: JCR Pharmaceuticals Co., Ltd.: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.19: JCR Pharmaceuticals Co., Ltd.: Overall Financials, 2016-2018
  • Figure 11.20: JCR Pharmaceuticals Co., Ltd.: Revenue (by Segment), 2016-2018
  • Figure 11.21: JCR Pharmaceuticals Co., Ltd.: SWOT Analysis
  • Figure 11.22: Mesoblast Ltd: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.23: Mesoblast Ltd: Overall Financials, 2016-2018
  • Figure 11.24: Mesoblast Ltd: R&D Expenditure (2016-2018)
  • Figure 11.25: Mesoblast Ltd: SWOT Analysis
  • Figure 11.26: NuVasive, Inc.: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.27: NuVasive, Inc.: Overall Financials, 2016-2018
  • Figure 11.28: NuVasive, Inc.: Revenue (by Segment), 2016-2018
  • Figure 11.29: NuVasive, Inc.: Revenue (by Region), 2016-2018
  • Figure 11.30: NuVasive, Inc.: R&D Expenditure (2016-2018)
  • Figure 11.31: NuVasive, Inc.: SWOT Analysis
  • Figure 11.32: Orthofix Holdings, Inc.: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.33: Orthofix Holdings, Inc.: Overall Financials, 2016-2018
  • Figure 11.34: Orthofix Holdings, Inc.: Revenue (by Segment), 2016-2018
  • Figure 11.35: Orthofix Holdings, Inc.: Revenue (by Country), 2016-2018
  • Figure 11.36: Orthofix Holdings, Inc.: R&D Expenditure (2016-2018)
  • Figure 11.37: Orthofix Holdings, Inc.: SWOT Analysis
  • Figure 11.38: Osiris Therapeutics, Inc.: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.39: Osiris Therapeutics, Inc.: Overall Financials, 2016-2018
  • Figure 11.40: Osiris Therapeutics, Inc.: Revenue (by Product), 2016-2018
  • Figure 11.41: Osiris Therapeutics, Inc.: R&D Expenditure (2016-2018)
  • Figure 11.42: Osiris Therapeutics, Inc.: SWOT Analysis
  • Figure 11.43: Regenexx: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.44: Regenexx: SWOT Analysis
  • Figure 11.45: Reliance Life Sciences Private Limited: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.46: Reliance Life Sciences Private Limited: SWOT Analysis
  • Figure 11.47: Takeda Pharmaceutical Company Limited: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.48: Takeda Pharmaceutical Company Limited: Overall Financials, 2016-2018
  • Figure 11.49: Takeda Pharmaceutical Company Limited: Revenue (by Region), 2016-2018
  • Figure 11.50: Takeda Pharmaceutical Company Limited: R&D Expenditure (2016-2018)
  • Figure 11.51: Takeda Pharmaceutical Company Limited: SWOT Analysis
  • Figure 11.52: U.S. Stem Cell, Inc.: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.53: U.S. Stem Cell, Inc.: SWOT Analysis
  • Figure 11.54: Vericel Corporation: Product Portfolio for Global Stem Cell Therapy Market
  • Figure 11.55: Vericel Corporation: Overall Financials, 2016-2018
  • Figure 11.56: Vericel Corporation: Revenue (by Product), 2016-2018
  • Figure 11.57: Vericel Corporation: R&D Expenditure (2016-2018)
  • Figure 11.58: Vericel Corporation: SWOT Analysis
目次
Product Code: BH154A

"Global Stem Cell Therapy Market to Grow at a CAGR of 27.99% from 2019-2029."

Key Questions Answered in this Report:

  • What is the therapeutic potential of stem cells and what are the major application areas of stem cell therapy?
  • What are the key trends of the global stem cell therapy market? How is the market evolving and what is its future scope?
  • What are the major drivers, challenges, and opportunities of the global stem cell therapy market?
  • What are the key developmental strategies implemented by the key players of the global stem cell therapy market to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?
  • Which are the key companies offering stem cell therapy products and which are the other companies dealing in stem cell therapies and have their products in the pipeline?
  • Which are the leading companies dominating the global stem cell therapy market? What was the market share of each of the key players of the global stem cell therapy market in 2018?
  • What is the regulatory scenario of the global stem cell therapy market? What are the initiatives implemented by different governmental bodies to promote research involving stem cells?
  • What was the market size of the global stem cell therapy market in 2018 and what is the market size anticipated to be in 2029? What is the expected growth rate of the global stem cell therapy market during the time period between 2019 and 2029?
  • What are the different treatment types of stem cell therapy? Which treatment type dominates the market in 2018 and why? Which treatment type is expected to witness highest growth rate and to dominate in market in 2029?
  • Which cell source type is leading the market in 2019 and which one is anticipated to witness massive rise in the demand in the forecast period between 2019?
  • What are the potential indication areas of stem cell therapy? Which indication type is leading the market in 2018 and which indication type is anticipated to dominate the market in next 10 years? What are the different regulatory designations controlling stem cell therapy products and how are those affecting the growth of the global stem cell therapy market?
  • What was the market value of the leading segments and sub-segments of the global stem cell therapy market? What are the different macro and micro factors influencing the growth of the market?
  • How is the industry expected to evolve during the forecast period 2019-2029? How is each segment of the global stem cell therapy market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2029?
  • Which region is expected to contribute the highest sales of the global stem cell therapy market during the time period between 2018 and 2029? Which region and country carries the potential for the significant expansion of key companies for different stem cell therapy products? What are the leading countries of different regions that contribute significantly toward the growth of the stem cell therapy market?
  • What are the key players of the global stem cell therapy market and what is their role in the market?

Global Stem Cell Therapy Market Forecast, 2019-2029

The Global Stem Cell Therapy Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 27.99% during the forecast period, 2019-2029.

The global stem cell therapy market growth has been primarily attributed to the major drivers in this market such as increasing prevalence of chronic diseases, rising number of clinical trials for cell-based therapy, steady investment and consolidation in the regenerative medicine market, and favorable regulatory environment. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include product approvals, declining product price and increasing adoption rate. However, there are significant challenges which are restraining the market growth. High treatment cost, exorbitant cost required for set up, and ethical considerations related to the use of embryonic stem cells are the challenges faced by the market.

Expert Quote

"Adipose tissue has gained significant attention in the past few years, acting as a rich source of multipotent stem cells, owing to the ease and minimally invasive process of derivation of stem cells from adipose tissue ."

Scope of the Market Intelligence on Stem Cell Therapy Market

The stem cell therapy market research provides a holistic view of the stem cell therapy market in terms of various factors influencing it, including regulatory reforms, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products allied with the therapeutic application of stem cells. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global stem cell therapy market.

Market Segmentation

  • The global stem cell therapy market is classified based on treatment type as allogenic and allogenic.
  • Based on the cell sources, the market is further segmented into five broad types i.e. bone marrow and peripheral blood, adipose tissue, umbilical cord and placenta, embryonic, and others.
  • Based on indication types, the market is further segmented into orthopaedic and dental, wounds and injuries, cardiology and neurology, immunology and inflammatory, oncology and metabolism, and others.
  • Based on geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest-of-the-World.

Key Companies in the Global Stem Cell Therapy Industry

The key manufacturers who have been contributing significantly to the global stem therapy market include Athersys, Inc., CORESTEM, Inc, FUJIFILM Cellular Dynamics, JCR Pharmaceuticals Co., Ltd., Mesoblast Ltd, NuVasive, Inc., Orthofix Holdings, Inc., Osiris Therapeutics, Inc., Takeda Pharmaceutical Company Limited, U.S. Stem Cell, Inc., Vericel Corporation, AlloSource, ANTEROGEN.CO., LTD., Regenexx, and Reliance Life Sciences Private Limited, among others.

Table of Contents

Executive Summary

1. Product Definition

2. Scope of the Work

  • 2.1. Overview: Report Scope
  • 2.2. Segmentation of the Global Stem Cell Therapy Market
  • 2.3. Assumptions and Limitations
  • 2.4. Key Questions Answered in the Report
  • 2.5. Base Year and Forecast Period

3. Research Methodology

  • 3.1. Overview: Report Methodology

4. Global Stem Cell Therapy Market

  • 4.1. Market Overview
  • 4.2. Introduction of Stem Cell Therapy
  • 4.3. Application of Stem Cells in Different Therapeutic Areas
  • 4.4. Market Dynamics
  • 4.5. Global Market Scenario
  • 4.6. Assumptions and Limitations

5. Competitive Landscape

  • 5.1. Overview
  • 5.2. Key Developments and Strategies
    • 5.2.1. Collaborations, and Partnerships
    • 5.2.2. Approvals and Clinical Studies
    • 5.2.3. Funding
    • 5.2.4. Business Expansions
    • 5.2.5. Product Launches and Developments
    • 5.2.6. Mergers and Acquisitions
    • 5.2.7. Others
  • 5.3. Market Share Analysis

6. Industry Insights

  • 6.1. Regulatory Scenario
  • 6.2. Regulatory Designations
  • 6.3. Expedited Designation Vs. Traditional Approval Timelines:
  • 6.4. Regulatory Challenges:

7. Global Stem Cell Therapy Market (by Treatment Type)

  • 7.1. Overview
  • 7.2. Key Trends of the Global Stem Cell Therapy Market (by Treatment Type)
  • 7.3. Autologous Treatment
  • 7.4. Allogenic Treatment

8. Global Stem Cell Therapy Market (by Cell Source)

  • 8.1. Overview
  • 8.2. Key Trends of the Global Stem Cell Therapy Market (by Cell Source)
  • 8.3. Bone Marrow and Peripheral Blood
  • 8.4. Adipose Tissue
  • 8.5. Placenta and Umbilical Cord
  • 8.6. Embryo
  • 8.7. Others

9. Global Stem Cell Therapy Market (by Indication)

  • 9.1. Overview
  • 9.2. Key Trends of the Global Stem Cell Therapy Market (by Indication)
  • 9.3. Orthopaedic and Dental
  • 9.4. Wounds and Injuries
  • 9.5. Cardiology and Neurology
  • 9.6. Immunology and Inflammatory
  • 9.7. Oncology and Metabolism
  • 9.8. Others

10. Global Stem Cell Therapy Market (by Region)

  • 10.1. Overview
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. U.S.
    • 10.2.3. Canada
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Germany
    • 10.3.3. U.K.
    • 10.3.4. France
    • 10.3.5. Italy
    • 10.3.6. Rest-of-Europe
  • 10.4. Asia-Pacific
    • 10.4.1. Overview
    • 10.4.2. Japan
    • 10.4.3. Australia
    • 10.4.4. China
    • 10.4.5. South Korea
    • 10.4.6. India
    • 10.4.7. Rest-of-Asia-Pacific
  • 10.5. Rest-of-the-World
    • 10.5.1. Overview
    • 10.5.2. Middle East and Africa
    • 10.5.3. Latin America

11. Company Profiles

  • 11.1. Overview
  • 11.2. AlloSource
    • 11.2.1. Company Overview
    • 11.2.2. Role of AlloSource in the Global Stem Cell Therapy Market
    • 11.2.3. SWOT Analysis
  • 11.3. ANTEROGEN.CO., LTD.
    • 11.3.1. Company Overview
    • 11.3.2. Role of ANTEROGEN.CO., LTD. In the Global Stem Cell Therapy Market
    • 11.3.3. SWOT Analysis
  • 11.4. Athersys Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Role of Athersys Inc. in the Global Stem Cell Therapy Market
    • 11.4.3. SWOT Analysis
  • 11.5. CORESTEM, Inc
    • 11.5.1. Company Overview
    • 11.5.2. Role of CORESTEM, Inc in the Global Stem Cell Therapy Market
    • 11.5.3. Financials
    • 11.5.4. SWOT Analysis
  • 11.6. FUJIFILM Cellular Dynamics, Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Role of FUJIFILM Cellular Dynamics, Inc. in the Global Stem Cell Therapy Market
    • 11.6.3. Financials
    • 11.6.4. SWOT Analysis
  • 11.7. JCR Pharmaceuticals Co., Ltd.
    • 11.7.1. Company Overview
    • 11.7.2. Role of JCR Pharmaceuticals Co., Ltd. In the Global Stem Cell Therapy Market
    • 11.7.3. Financials
    • 11.7.4. SWOT Analysis
  • 11.8. Mesoblast Ltd
    • 11.8.1. Company Overview
    • 11.8.2. Role of Mesoblast Ltd in the Global Stem Cell Therapy Market
    • 11.8.3. Financials
    • 11.8.4. SWOT Analysis
  • 11.9. NuVasive, Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Role of NuVasive, Inc. in the Global Stem Cell Therapy Market
    • 11.9.3. Financials
    • 11.9.4. SWOT Analysis
  • 11.10 Orthofix Holdings, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Role of Orthofix Holdings, Inc. in the Global Stem Cell Therapy Market
    • 11.10.3. Financials
    • 11.10.4. SWOT Analysis
  • 11.11 Osiris Therapeutics, Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Role of Osiris Therapeutics, Inc. in the Global Stem Cell Therapy Market
    • 11.11.3. Financials
    • 11.11.4. SWOT Analysis
  • 11.12 Regenexx
    • 11.12.1. Company Overview
    • 11.12.2. Role of Regenexx in the Global Stem Cell Therapy Market
    • 11.12.3. SWOT Analysis
  • 11.13 Reliance Life Sciences Private Limited
    • 11.13.1. Company Overview
    • 11.13.2. Role of Reliance Life Sciences Private Limited in the Global Stem Cell Therapy Market
    • 11.13.3. SWOT Analysis
  • 11.14 Takeda Pharmaceutical Company Limited
    • 11.14.1. Company Overview
    • 11.14.2. Role of Takeda Pharmaceutical Company Limited in the Global Stem Cell Therapy Market
    • 11.14.3. Financials
    • 11.14.4. SWOT Analysis
  • 11.15 U.S. Stem Cell, Inc.
    • 11.15.1. Company Overview
    • 11.15.2. Role of U.S. Stem Cell, Inc. in the Global Stem Cell Therapy Market
    • 11.15.3. SWOT Analysis
  • 11.16 Vericel Corporation
    • 11.16.1. Company Overview
    • 11.16.2. Role of Vericel Corporation in the Global Stem Cell Therapy Market
    • 11.16.3. Financials
    • 11.16.4. SWOT Analysis
Back to Top